Integrated regulatory models for inference of subtype-specific susceptibilities in glioblastoma.

Ramos, A, Koch, CE, Liu-Lupo, Y, Hellinger, RD, Kyung, T, Abbott, KL, Fröse, J, Goulet, D, Gordon, KS, Eidell, KP et al.. 2023. Nat Commun 14, 8048. 
doi: 10.1038/s41467-023-43790-2PMID:38052854

Previous
Previous

Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance.

Next
Next

Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening.